Table 2. Prevalence of STIs and HPV.
| Organism | n | % (95% CI) | Total n |
|---|---|---|---|
| HPV | |||
| Any HPV | 257 | 33.0 (29.7–36.3) | 779 |
| High-risk HPV1 | 172 | 22.1 (19.2–25.0) | 779 |
| STI | |||
| C. trachomatis | 5 | 0.6 (0.1–1.2) | 779 |
| T. vaginalis | 18 | 2.3 (1.3–3.4) | 779 |
| N. gonorrhoeae | 5 | 0.6 (0.1–1.2) | 779 |
| M. genitalium | 8 | 1.0 (0.3–1.7) | 779 |
| HSV-2 | 12 | 1.5 (0.7–2.4) | 779 |
| HSV-1 | 3 | 0.4 (0.1–1.2) | 779 |
| STI-positive2 | 48 | 6.2 (4.5–7.9) | 779 |
| BV | |||
| A. vaginae | 218 | 28.0 (24.8–31.1) | 779 |
| G. vaginalis | 301 | 38.6 (35.2–42.1) | 779 |
| M. hominis | 78 | 10.0 (7.9–12.1) | 779 |
| L. iners | 489 | 62.8 (59.4–66.2) | 779 |
| Any lactobacillus | 741 | 95.1 (93.6–96.6) | 779 |
| BV-score 1 | 19 | 3.7 (2.0–5.3) | 5184 |
| BV-score 2 | 49 | 9.5 (6.9–12.0) | 5184 |
| BV-score 3 | 7 | 1.4 (0.4–2.3) | 5184 |
| BV-score 4 | 44 | 8.5 (6.1–10.9) | 5184 |
| BV-score 5 | 26 | 5.0 (3.1–6.9) | 5184 |
| BV-score ≥ 23 | 126 | 24.3 (20.6–28.0) | 5184 |
| Candida | |||
| C. albicans | 222 | 28.5 (25.3–31.7) | 779 |
| C. glabrata | 55 | 7.1 (5.3–8.9) | 779 |
| C. krusei | 36 | 4.6 (3.1–6.1) | 779 |
| Candida species | 301 | 38.6 (35.2–42.1) | 779 |
| Other Mycoplasma and Ureaplasma | |||
| M. spermatophilum | 1 | 0.1 (0.01–0.8) | 779 |
| U. urealyticum | 152 | 19.5 (16.7–22.3) | 779 |
| U. parvum | 427 | 54.8 (51.3–58.3) | 779 |
This table shows all detected organisms. No cases of T. pallidum or M. pneumoniae were found.
1
High-risk HPV types: HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68a/b
2
STI-positives include women positive for M. genitalium, C. trachomatis, N. gonorrhoeae, T. vaginalis, T. pallidum or HSV-1/2
3
BV-score takes low levels of lactobacillus and positivity for G. vaginalis, A. vaginae and M. hominis into account
4
BV-scores could only be calculated for samples with quantifiable Lactobacillus